Conversations on Cancer: How Biotech Built a Blockbuster Cancer Drug

Conversations on Cancer: How Biotech Built a Blockbuster Cancer Drug

Conversations on Cancer: Bringing Innovation to People Facing CancerSee more

Conversations on Cancer: Bringing Innovation to People Facing Cancer

The new cancer drugs - Helpful or harmful? | DW DocumentarySee more

The new cancer drugs - Helpful or harmful? | DW Documentary

How Scientific Teams Develop New Anti Cancer DrugsSee more

How Scientific Teams Develop New Anti Cancer Drugs

Cancer drugs 💊See more

Cancer drugs 💊

The Science Behind Lantern Pharma's Cancer Drug DevelopmentSee more

The Science Behind Lantern Pharma's Cancer Drug Development

50 Years and Counting: Engaging the Generations on Future Cancer Equity OpportunitiesSee more

50 Years and Counting: Engaging the Generations on Future Cancer Equity Opportunities

BioNeex Interview with Dr. Hitesh Mistry from Physiomics - Cancer Drug LicensingSee more

BioNeex Interview with Dr. Hitesh Mistry from Physiomics - Cancer Drug Licensing

Cancer Moonshot in Action: Launching the Next Generation of Cancer LeadersSee more

Cancer Moonshot in Action: Launching the Next Generation of Cancer Leaders

Nanoparticle-based drug delivery in the fight against cancerSee more

Nanoparticle-based drug delivery in the fight against cancer

How Novartis develops blockbuster drugsSee more

How Novartis develops blockbuster drugs

Ask A Scientist: Making Targeted Cancer DrugsSee more

Ask A Scientist: Making Targeted Cancer Drugs

The Two Themes Transforming Cancer Drug TreatmentsSee more

The Two Themes Transforming Cancer Drug Treatments

Pfizer buys Washington-based biotech developer to improve access to cancer treatmentsSee more

Pfizer buys Washington-based biotech developer to improve access to cancer treatments

Revolutionary Drug that Treats CancerSee more

Revolutionary Drug that Treats Cancer

Why Novartis focuses on cancer drugsSee more

Why Novartis focuses on cancer drugs

CANCER TREATMENT TRUTHSee more

CANCER TREATMENT TRUTH

AstraZeneca 'within striking distance' of curing some cancers, CEO says | CNBC ConversationSee more

AstraZeneca 'within striking distance' of curing some cancers, CEO says | CNBC Conversation

Cancer bioscience: too focused on drug discovery?See more

Cancer bioscience: too focused on drug discovery?

AI-designed HyperFood against cancer | Michael Bronstein & Kirill Veselkov | TEDxLuganoSee more

AI-designed HyperFood against cancer | Michael Bronstein & Kirill Veselkov | TEDxLugano

Actual